Citations (123)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Sirasa Ruangritchankul, Prawat Chantharit, Sahaphume Srisuma & Leonard C Gray. (2021) Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review. Therapeutics and Clinical Risk Management 17, pages 927-949.
Read now
Read now
Huaqiao Tang, Nana Long, Lin Lin, Yao Liu, Jianlong Li, Fenghui Sun, Lijuan Guo, Fen Zhang & Min Dai. (2018) Effect of MRSA on CYP450: dynamic changes of cytokines, oxidative stress, and drug-metabolizing enzymes in mice infected with MRSA. Infection and Drug Resistance 11, pages 229-238.
Read now
Read now
Carla Carnovale, Emanuel Raschi, Luca Leonardi, Ugo Moretti, Fabrizio De Ponti, Marta Gentili, Marco Pozzi, Emilio Clementi, Elisabetta Poluzzi & Sonia Radice. (2018) No signal of interactions between influenza vaccines and drugs used for chronic diseases: a case-by-case analysis of the vaccine adverse event reporting system and vigibase. Expert Review of Vaccines 17:4, pages 363-381.
Read now
Read now
Emily Reeve, Shanna C Trenaman, Kenneth Rockwood & Sarah N Hilmer. (2017) Pharmacokinetic and pharmacodynamic alterations in older people with dementia. Expert Opinion on Drug Metabolism & Toxicology 13:6, pages 651-668.
Read now
Read now
Sharon M. Seifert, Jose R. Castillo-Mancilla, Kristine M. Erlandson & Peter L. Anderson. (2017) Inflammation and pharmacokinetics: potential implications for HIV-infection. Expert Opinion on Drug Metabolism & Toxicology 13:6, pages 641-650.
Read now
Read now
Roos Achterbergh, Laureen A. Lammers, Samuel van Nierop, Heinz-Josef Klümpen, Maarten R. Soeters, Ron A. A. Mathôt & Johannes A. Romijn. (2016) A short-term high fat diet increases exposure to midazolam and omeprazole in healthy subjects. Expert Opinion on Drug Metabolism & Toxicology 12:7, pages 715-720.
Read now
Read now
Zhi-Xu He, Xiao-Wu Chen, Zhi-Wei Zhou & Shu-Feng Zhou. (2015) Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine. Drug Metabolism Reviews 47:4, pages 470-519.
Read now
Read now
Derek J Roberts & Richard I Hall. (2013) Drug absorption, distribution, metabolism and excretion considerations in critically ill adults. Expert Opinion on Drug Metabolism & Toxicology 9:9, pages 1067-1084.
Read now
Read now
Bernard Bannwarth, Marie Kostine & Nicolas Poursac. (2013) A pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritis. Expert Opinion on Drug Metabolism & Toxicology 9:6, pages 753-761.
Read now
Read now
Sabine Gerbal-Chaloin, Irena Iankova, Patrick Maurel & Martine Daujat-Chavanieu. (2013) Nuclear receptors in the cross-talk of drug metabolism and inflammation. Drug Metabolism Reviews 45:1, pages 122-144.
Read now
Read now
Zeruesenay Desta, Ruin Moaddel, Evan T. Ogburn, Cong Xu, Anuradha Ramamoorthy, Swarajya Lakshmi Vattem Venkata, Mitesh Sanghvi, Michael E. Goldberg, Marc C. Torjman & Irving W. Wainer. (2012) Stereoselective and regiospecific hydroxylation of ketamine and norketamine. Xenobiotica 42:11, pages 1076-1087.
Read now
Read now
Neill James Liptrott & Andrew Owen. (2011) The role of cytokines in the regulation of drug disposition: extended functional pleiotropism?. Expert Opinion on Drug Metabolism & Toxicology 7:3, pages 341-352.
Read now
Read now
Laura MacDonald, Mano Murty & Brian C Foster. (2009) Antiviral drug disposition and natural health products: risk of therapeutic alteration and resistance. Expert Opinion on Drug Metabolism & Toxicology 5:6, pages 563-578.
Read now
Read now
Articles from other publishers (110)
Eva Sanchez-Quant, Maria Lucia Richter, Maria Colomé-Tatché & Celia Pilar Martinez-Jimenez. (2023) Single-cell metabolic profiling reveals subgroups of primary human hepatocytes with heterogeneous responses to drug challenge. Genome Biology 24:1.
Crossref
Crossref
Juan Manuel Serrano-Rodríguez, Emilio Fernández-Varón, Carlos Mario Cárceles Rodríguez, Manuel Ignacio San Andrés-Larrea, Sonia Rubio-Langre, Christian de la Fe, Samanta Waxman Dova, Pallavi Bhardwaj, Pritam Kaur Sidhu, Nicolás Javier Litterio & Augusto Matías Lorenzutti. (2023) Population pharmacokinetics and pharmacokinetic/pharmacodynamic evaluation of marbofloxacin against Coagulase-negative staphylococci, Staphylococcus aureus and Mycoplasma agalactiae pathogens in goats. Research in Veterinary Science 159, pages 1-10.
Crossref
Crossref
Eliza R. McColl, Maria A. Croyle, William C. Zamboni, William G. Honer, Mark Heise, Micheline Piquette-Miller & Kerry B. Goralski. (2023) COVID-19 Vaccines and the Virus: Impact on Drug Metabolism and Pharmacokinetics. Drug Metabolism and Disposition 51:1, pages 130-141.
Crossref
Crossref
Lyubov S. Klyushova, Maria L. Perepechaeva & Alevtina Y. Grishanova. (2022) The Role of CYP3A in Health and Disease. Biomedicines 10:11, pages 2686.
Crossref
Crossref
Xiaokang Wang, Jiaoyu Rao, Zhiyi Tan, Tianrong Xun, Jingqian Zhao & Xixiao Yang. (2022) Inflammatory signaling on cytochrome P450-mediated drug metabolism in hepatocytes. Frontiers in Pharmacology 13.
Crossref
Crossref
Azam Hosseinzadeh, Abolfazl Bagherifard, Fereshteh Koosha, Shiva Amiri, Arman Karimi-Behnagh, Russel J. Reiter & Saeed Mehrzadi. (2022) Melatonin effect on platelets and coagulation: Implications for a prophylactic indication in COVID-19. Life Sciences 307, pages 120866.
Crossref
Crossref
Ann‐Cathrine Dalgård Dunvald, Erkka Järvinen, Christina Mortensen & Tore B. Stage. (2021) Clinical and Molecular Perspectives on Inflammation‐Mediated Regulation of Drug Metabolism and Transport. Clinical Pharmacology & Therapeutics 112:2, pages 277-290.
Crossref
Crossref
Peter Lees, Pierre‐Louis Toutain, Jonathan Elliott, Jerome M. Giraudel, Ludovic Pelligand & Jonathan N. King. (2022) Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib. Journal of Veterinary Pharmacology and Therapeutics 45:4, pages 325-351.
Crossref
Crossref
Christian Knöchel, Gudrun Hefner, Thomas Stiehl & Walter Schmidbauer. (2022) Elevated Clozapine Blood Concentrations After Second COVID-19 Vaccination With Spikevax (COVID-19 Vaccine Moderna). Journal of Clinical Psychopharmacology 42:3, pages 317-320.
Crossref
Crossref
Daniela Gabbia, Marco Roverso, Samantha Sarcognato, Ilaria Zanotto, Nicola Ferri, Francesco Paolo Russo, Maria Guido, Sara Bogialli & Sara De Martin. (2022) The Metabolic Activation of Sofosbuvir Is Impaired in an Experimental Model of NAFLD. Biology 11:5, pages 693.
Crossref
Crossref
Yong-Soon Cho, Kyun-Seop Bae, Seung Chan Choi, Joong Myung Cho & Hyeong-Seok Lim. (2022) Population Pharmacokinetic and Pharmacodynamic Analysis of Polmacoxib in Healthy Volunteers and Patients With Osteoarthritis. Clinical Therapeutics 44:1, pages 67-80.e1.
Crossref
Crossref
Zunera Chauhdary, Kanwal Rehman, Muhammad Sajid Hamid Akash, Shaleem Suhail, Momina Shahid & Sardar Sindhu. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
323
345
.
Saskia Rietjens & Dylan de Lange. 2022. The Very Old Critically Ill Patients. The Very Old Critically Ill Patients
91
107
.
Debasish Basak, Scott Arrighi, Yasenya Darwiche & Subrata Deb. (2021) Comparison of Anticancer Drug Toxicities: Paradigm Shift in Adverse Effect Profile. Life 12:1, pages 48.
Crossref
Crossref
Imke H. Bartelink, Pierre M. Bet, Nicolas Widmer, Monia Guidi, Erik Duijvelaar, Bram Grob, Richard Honeywell, Amanda Evelo, Ivo P. E. Tielbeek, Sue D. Snape, Henrike Hamer, Laurent A. Decosterd, Harm Jan Bogaard, Jurjan Aman & Eleonora L. Swart. (2021) Elevated acute phase proteins affect pharmacokinetics in COVID‐19 trials: Lessons from the CounterCOVID ‐ imatinib study. CPT: Pharmacometrics & Systems Pharmacology 10:12, pages 1497-1511.
Crossref
Crossref
Camille Lenoir, Victoria Rollason, Jules A. Desmeules & Caroline F. Samer. (2021) Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature. Frontiers in Pharmacology 12.
Crossref
Crossref
Augusto Matías Lorenzutti, Juan Pablo Vico, Juan Manuel Serrano-Rodríguez, Martín Alejandro Himelfarb, Manuel Ignacio San Andrés-Larrea, José Julio de Lucas-Burneo & Nicolás Javier Litterio. (2021) PK/PD Analysis by Nonlinear Mixed-Effects Modeling of a Marbofloxacin Dose Regimen for Treatment of Goat Mastitis Produced by Coagulase-Negative Staphylococci. Animals 11:11, pages 3098.
Crossref
Crossref
Mehmet Nihat Ural & Kamil Uney. (2021) Pharmacokinetic Behavior and Pharmacokinetic/Pharmacodynamic Integration of Danofloxacin Following Single or Co-Administration with Meloxicam in Healthy Lambs and Lambs with Respiratory Infections. Antibiotics 10:10, pages 1190.
Crossref
Crossref
Sonia Saib & Xavier Delavenne. (2021) Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition. Pharmaceutics 13:10, pages 1544.
Crossref
Crossref
Yurong Song, Chenxi Li, Guangzhi Liu, Rui Liu, Youwen Chen, Wen Li, Zhiwen Cao, Baosheng Zhao, Cheng Lu & Yuanyan Liu. (2021) Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes. Clinical Pharmacokinetics 60:5, pages 585-601.
Crossref
Crossref
Yan-Nan Zang, Fang Dong, An-Ning Li, Chuan-Yue Wang, Gui-Xin Guo, Qian Wang, Yan-Fang Zhang, Lei Zhang, Jose de Leon & Can-Jun Ruan. (2021) The Impact of Smoking, Sex, Infection, and Comedication Administration on Oral Olanzapine: A Population Pharmacokinetic Model in Chinese Psychiatric Patients. European Journal of Drug Metabolism and Pharmacokinetics 46:3, pages 353-371.
Crossref
Crossref
Anne Cristine Almeida, Anna Beatriz Ribeiro Elias, Maria Paula Marques, Gisely Cardoso de Melo, Allyson Guimarães da Costa, Erick Frota Gomes Figueiredo, Larissa Wanderley Brasil, Fernanda Rodrigues‐Soares, Wuelton Marcelo Monteiro, Marcus Vinicius Guimarães de Lacerda, Vera Lucia Lanchote & Guilherme Suarez‐Kurtz. (2020)
Impact of
Plasmodium vivax
malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients
. British Journal of Clinical Pharmacology 87:4, pages 1859-1868.
Crossref
Crossref
Ana C.A.X. De-Oliveira & Francisco J.R. Paumgartten. (2021) Malaria-induced Alterations of Drug Kinetics and Metabolism in Rodents and Humans. Current Drug Metabolism 22:2, pages 127-138.
Crossref
Crossref
Subrata Deb & Scott Arrighi. (2021) Potential Effects of COVID-19 on Cytochrome P450-Mediated Drug Metabolism and Disposition in Infected Patients. European Journal of Drug Metabolism and Pharmacokinetics 46:2, pages 185-203.
Crossref
Crossref
Atiwat Soontornpun, Natthakarn Manoyana, Nattayaporn Apaijai, Kanokporn Pinyopornpanish, Kanokwan Pinyopornpanish, Angkana Nadsasarn, Surat Tanprawate, Nipon Chattipakorn & Siriporn C. Chattipakorn. (2020) Influenza immunization does not predominantly alter levels of phenytoin, and cytochrome P-450 enzymes in epileptic patients receiving phenytoin monotherapy. Epilepsy Research 167, pages 106471.
Crossref
Crossref
Catia Marzolini, Felix Stader, Marcel Stoeckle, Fabian Franzeck, Adrian Egli, Stefano Bassetti, Alexa Hollinger, Michael Osthoff, Maja Weisser, Caroline E. Gebhard, Veronika Baettig, Julia Geenen, Nina Khanna, Sarah Tschudin-Sutter, Daniel Mueller, Hans H. Hirsch, Manuel Battegay & Parham Sendi. (2020) Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations. Antimicrobial Agents and Chemotherapy 64:9.
Crossref
Crossref
Marilyn N. Martinez, Jonathan Greene, Leslie Kenna, Lindsey Kissell & Matt Kuhn. (2020) The Impact of Infection and Inflammation on Drug Metabolism, Active Transport, and Systemic Drug Concentrations in Veterinary Species. Drug Metabolism and Disposition 48:8, pages 631-644.
Crossref
Crossref
Maaike A. Sikma, Claudine C. Hunault, Alwin D. R. Huitema, Dylan W. De Lange & Erik M. Van Maarseveen. (2019) Clinical Pharmacokinetics and Impact of Hematocrit on Monitoring and Dosing of Tacrolimus Early After Heart and Lung Transplantation. Clinical Pharmacokinetics 59:4, pages 403-408.
Crossref
Crossref
Liying Gong, Chengxiao Fu, Lucun Bi, Yun Kuang, Chengxian Guo, Guolan Wei, Zhaofeng Yan, Jie Huang & Guoping Yang. (2019) Pharmacokinetics and bioequivalence of low-dose clopidogrel in healthy Chinese volunteers under fasted and fed conditions. Drug Metabolism and Pharmacokinetics 34:5, pages 300-307.
Crossref
Crossref
Genny Raffaeli, Pavla Pokorna, Karel Allegaert, Fabio Mosca, Giacomo Cavallaro, Enno D. Wildschut & Dick Tibboel. (2019) Drug Disposition and Pharmacotherapy in Neonatal ECMO: From Fragmented Data to Integrated Knowledge. Frontiers in Pediatrics 7.
Crossref
Crossref
Jun-Jun He, Jun Ma, Jin-Lei Wang, Fu-Kai Zhang, Jie-Xi Li, Bin-Tao Zhai, Ze-Xiang Wang, Hany M. Elsheikha & Xing-Quan Zhu. (2019) Global Transcriptome Profiling of Multiple Porcine Organs Reveals Toxoplasma gondii-Induced Transcriptional Landscapes. Frontiers in Immunology 10.
Crossref
Crossref
. 2019. Demystifying Drug Dosing in Renal Dysfunction. Demystifying Drug Dosing in Renal Dysfunction
153
170
.
S. Imindu Liyanage, Prachi Vilekar & Donald F. Weaver. (2019) Nutrients in Alzheimer’s Disease: The Interaction of Diet, Drugs and Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 46:1, pages 23-34.
Crossref
Crossref
Kuo-Chen Wu & Chun-Jung Lin. (2019) The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders. Journal of Food and Drug Analysis 27:1, pages 48-59.
Crossref
Crossref
Melanie R. Nicol, Joseph A. Corbino & Mackenzie L. Cottrell. (2018) Pharmacology of Antiretrovirals in the Female Genital Tract for HIV Prevention. The Journal of Clinical Pharmacology 58:11, pages 1381-1395.
Crossref
Crossref
Birgit M. Wollmann, Silje Watterdal Syversen, Maria Vistnes, Elisabeth Lie, Lise L. Mehus & Espen Molden. (2018) Associations between Cytokine Levels and CYP3A4 Phenotype in Patients with Rheumatoid Arthritis. Drug Metabolism and Disposition 46:10, pages 1384-1389.
Crossref
Crossref
Bas Vreugdenhil, Walter J. F. M. van der Velden, Ton Feuth, Matthijs Kox, Peter Pickkers, Frank L. van de Veerdonk, Nicole M. A. Blijlevens & Roger J. M. Brüggemann. (2018) Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole. British Journal of Clinical Pharmacology 84:9, pages 1980-1988.
Crossref
Crossref
Abdulla A.-B. Badawy. (2018) Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease. Medical Hypotheses 118, pages 129-138.
Crossref
Crossref
Yi-jin Wu, Chun Wang & Wei Wei. (2018) The effects of DMARDs on the expression and function of P-gp, MRPs, BCRP in the treatment of autoimmune diseases. Biomedicine & Pharmacotherapy 105, pages 870-878.
Crossref
Crossref
Robert L. Smith, Samuel M. Cohen, Shoji Fukushima, Nigel J. Gooderham, Stephen S. Hecht, F. Peter Guengerich, Ivonne M. C. M. Rietjens, Maria Bastaki, Christie L. Harman, Margaret M. McGowen & Sean V. Taylor. (2018) The safety evaluation of food flavouring substances: the role of metabolic studies. Toxicology Research 7:4, pages 618-646.
Crossref
Crossref
Atsushi Kawase, Shunsuke Tateishi & Akira Kazaoka. (2018) Profiling of hepatic metabolizing enzymes and nuclear receptors in rats with adjuvant arthritis by targeted proteomics. Biopharmaceutics & Drug Disposition 39:6, pages 308-314.
Crossref
Crossref
Anne van Rongen, Margreke J. E. Brill, Janelle D. Vaughns, Pyry A. J. Välitalo, Eric P. A. van Dongen, Bert van Ramshorst, Jeffrey S. Barrett, Johannes N. van den Anker & Catherijne A. J. Knibbe. (2017) Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults. Clinical Pharmacokinetics 57:5, pages 601-611.
Crossref
Crossref
J.P. Luyendyk, P.E. Ganey, A. Fullerton & R.A. Roth. 2018. Comprehensive Toxicology. Comprehensive Toxicology
324
345
.
Kerry B. Goralski, Matthew A. Ladda & Jenna O. McNeil. 2018. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions
163
204
.
Xiaonan Li, Debra C. DuBois, Richard R. Almon & William J. Jusko. (2017) Modeling Sex Differences in Pharmacokinetics, Pharmacodynamics, and Disease Progression Effects of Naproxen in Rats with Collagen-Induced Arthritis. Drug Metabolism and Disposition 45:5, pages 484-491.
Crossref
Crossref
Xiaonan Li, Debra C. DuBois, Richard R. Almon & William J. Jusko. (2017) Effect of Disease-Related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats. Drug Metabolism and Disposition 45:5, pages 476-483.
Crossref
Crossref
Edwin N. Aroke, Sybil L. Crawford & Jennifer R. Dungan. (2017) Pharmacogenetics of Ketamine-Induced Emergence Phenomena. Nursing Research 66:2, pages 105-114.
Crossref
Crossref
BM Wollmann, SW Syversen, E Lie, C Gjestad, LL Mehus, IC Olsen & E Molden. (2017)
4
β
-Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State
. Clinical and Translational Science 10:1, pages 42-49.
Crossref
Crossref
Anette Veringa, Mendy ter Avest, Lambert F. R. Span, Edwin R. van den Heuvel, Daan J. Touw, Jan G. Zijlstra, Jos G. W. Kosterink, Tjip S. van der Werf & Jan-Willem C. Alffenaar. (2017) Voriconazole metabolism is influenced by severe inflammation: a prospective study. Journal of Antimicrobial Chemotherapy 72:1, pages 261-267.
Crossref
Crossref
E.T. Morgan. 2017. Drug Metabolism in Diseases. Drug Metabolism in Diseases
21
58
.
Jun-Jun He, Jun Ma, Hany M. Elsheikha, Hui-Qun Song, Si-Yang Huang & Xing-Quan Zhu. (2016) Transcriptomic analysis of mouse liver reveals a potential hepato-enteric pathogenic mechanism in acute Toxoplasma gondii infection. Parasites & Vectors 9:1.
Crossref
Crossref
Anne Kummer, Gopala Nishanth, Josephin Koschel, Frank Klawonn, Dirk Schlüter & Lothar Jänsch. (2016) Listeriosis downregulates hepatic cytochrome P450 enzymes in sublethal murine infection. PROTEOMICS – Clinical Applications 10:9-10, pages 1025-1035.
Crossref
Crossref
M. A. Encalada Ventura, M. J. P. van Wanrooy, L. F. R. Span, M. G. G. Rodgers, E. R. van den Heuvel, D. R. A. Uges, T. S. van der Werf, J. G. W. Kosterink & J. W. C. Alffenaar. (2016) Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough Concentrations. Antimicrobial Agents and Chemotherapy 60:5, pages 2727-2731.
Crossref
Crossref
Gudrun Hefner, Mohamed E. E. Shams, Stefan Unterecker, Tanja Falter & Christoph Hiemke. (2015) Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels. Psychopharmacology 233:9, pages 1695-1705.
Crossref
Crossref
R. Pérez, C. Palma, R. Burgos, J. A. Jeldres, A. Espinoza & A. K. Peñailillo. (2016)
The acute phase response induced by
Escherichia coli
lipopolysaccharide modifies the pharmacokinetics and metabolism of florfenicol in rabbits
. Journal of Veterinary Pharmacology and Therapeutics 39:2, pages 183-190.
Crossref
Crossref
Anna A. Shvedova, Elena R. Kisin, Naveena Yanamala, Mariana T. Farcas, Autumn L. Menas, Andrew Williams, Philip M. Fournier, Jeffrey S. Reynolds, Dmitriy W. Gutkin, Alexander Star, Richard S. Reiner, Sabina Halappanavar & Valerian E. Kagan. (2016) Gender differences in murine pulmonary responses elicited by cellulose nanocrystals. Particle and Fibre Toxicology 13:1.
Crossref
Crossref
Joseph L. Tan, Jacques G. Eastment, Arjun Poudel & Ruth E. Hubbard. (2015) Age-Related Changes in Hepatic Function: An Update on Implications for Drug Therapy. Drugs & Aging 32:12, pages 999-1008.
Crossref
Crossref
Margreke J. Brill, Anne van Rongen, Eric P. van Dongen, Bert van Ramshorst, Eric J. Hazebroek, Adam S. Darwich, Amin Rostami-Hodjegan & Catherijne A. Knibbe. (2015) The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery. Pharmaceutical Research 32:12, pages 3927-3936.
Crossref
Crossref
Gudrun Hefner, Tanja Falter, Kai Bruns & Christoph Hiemke. (2015) Elevated risperidone serum concentrations during acute inflammation, two cases. The International Journal of Psychiatry in Medicine 50:3, pages 335-344.
Crossref
Crossref
Paolo Pellegrino, Cristiana Perrotta, Emilio Clementi & Sonia Radice. (2015) Vaccine–Drug Interactions: Cytokines, Cytochromes, and Molecular Mechanisms. Drug Safety 38:9, pages 781-787.
Crossref
Crossref
Robert S. Foti, Rachel F. Tyndale, Kristine L. P. Garcia, Douglas H. Sweet, Swati Nagar, Satish Sharan & Dan A. Rock. (2015) “Target-Site” Drug Metabolism and Transport. Drug Metabolism and Disposition 43:8, pages 1156-1168.
Crossref
Crossref
Scott Thomson, Matthew L. Edin, Fred B. Lih, Michael Davies, Muhammad M. Yaqoob, Bruce D. Hammock, Derek Gilroy, Darryl C. Zeldin & David Bishop-Bailey. (2015) Intimal smooth muscle cells are a source but not a sensor of anti-inflammatory CYP450 derived oxylipins. Biochemical and Biophysical Research Communications 463:4, pages 774-780.
Crossref
Crossref
E. G. Quetglas, A. Armuzzi, S. Wigge, G. Fiorino, L. Barnscheid, M. Froelich & Silvio Danese. (2015) Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment. European Journal of Clinical Pharmacology 71:7, pages 773-799.
Crossref
Crossref
R. Pérez, C. Palma, C. Drápela, M. Sepulveda, A. Espinoza & A. K. Peñailillo. (2015)
Pharmacokinetics of florfenicol after intravenous administration in
Escherichia coli
lipopolysaccharide-induced endotoxaemic sheep
. Journal of Veterinary Pharmacology and Therapeutics 38:2, pages 144-149.
Crossref
Crossref
Rashmi R. Shah & Robert L. Smith. (2015) Inflammation-Induced Phenoconversion of Polymorphic Drug Metabolizing Enzymes: Hypothesis with Implications for Personalized Medicine. Drug Metabolism and Disposition 43:3, pages 400-410.
Crossref
Crossref
Marcus Klein, Maria Thomas, Ute Hofmann, Daniel Seehofer, Georg Damm & Ulrich M. Zanger. (2015) A Systematic Comparison of the Impact of Inflammatory Signaling on Absorption, Distribution, Metabolism, and Excretion Gene Expression and Activity in Primary Human Hepatocytes and HepaRG Cells. Drug Metabolism and Disposition 43:2, pages 273-283.
Crossref
Crossref
Paolo Pellegrino, Emilio Clementi, Annalisa Capuano & Sonia Radice. (2015) Can vaccines interact with drug metabolism?. Pharmacological Research 92, pages 13-17.
Crossref
Crossref
Lenka Šmerdová, Jana Svobodová, Markéta Kabátková, Jiří Kohoutek, Dalibor Blažek, Miroslav Machala & Jan Vondráček. (2014) Upregulation of CYP1B1 expression by inflammatory cytokines is mediated by the p38 MAP kinase signal transduction pathway. Carcinogenesis 35:11, pages 2534-2543.
Crossref
Crossref
Sylvie M. Mimche, Beatrice A. Nyagode, Matthew D. Merrell, Choon-Myung Lee, Nina S. Prasanphanich, Richard D. Cummings & Edward T. Morgan. (2014)
Hepatic Cytochrome P450s, Phase II Enzymes and Nuclear Receptors Are Downregulated in a Th2 Environment during
Schistosoma mansoni
Infection
. Drug Metabolism and Disposition 42:1, pages 134-140.
Crossref
Crossref
P. N. Morcos, S. A. Moreira, B. J. Brennan, S. Blotner, N. S. Shulman & P. F. Smith. (2013) Influence of chronic hepatitis C infection on cytochrome P450 3a4 activity using midazolam as an in vivo probe substrate. European Journal of Clinical Pharmacology 69:10, pages 1777-1784.
Crossref
Crossref
Xiaoping Zhang & Barbara J. Brennan. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
16
.
Nisanne Ghonem, Junichi Yoshida, Noriko Murase, Stephen C. Strom & Raman Venkataramanan. (2012) Treprostinil Improves Hepatic Cytochrome P450 Activity during Rat Liver Transplantation. Journal of Clinical and Experimental Hepatology 2:4, pages 323-332.
Crossref
Crossref
Carlos A. ZarateJr.Jr., Nancy Brutsche, Gonzalo Laje, David A. Luckenbaugh, Swarajya L. Vattem Venkata, Anuradha Ramamoorthy, Ruin Moaddel & Irving W. Wainer. (2012) Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression. Biological Psychiatry 72:4, pages 331-338.
Crossref
Crossref
Márcia Carvalho, Helena Carmo, Vera Marisa Costa, João Paulo Capela, Helena Pontes, Fernando Remião, Félix Carvalho & Maria de Lourdes Bastos. (2012) Toxicity of amphetamines: an update. Archives of Toxicology 86:8, pages 1167-1231.
Crossref
Crossref
Hadi Molanaei, Peter Stenvinkel, Abdul Rashid Qureshi, Juan Jesús Carrero, Olof Heimbürger, Bengt Lindholm, Ulf Diczfalusy, Ingegerd Odar-Cederlöf & Leif Bertilsson. (2011) Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation. European Journal of Clinical Pharmacology 68:5, pages 571-577.
Crossref
Crossref
Zdenek Dvorak. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics
223
258
.
A. J. McLachlan & L. G. Pont. (2011) Drug Metabolism in Older People--A Key Consideration in Achieving Optimal Outcomes With Medicines. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 67A:2, pages 175-180.
Crossref
Crossref
April D. Lake, Petr Novak, Craig D. Fisher, Jonathan P. Jackson, Rhiannon N. Hardwick, D. Dean Billheimer, Walter T. Klimecki & Nathan J. Cherrington. (2011) Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition 39:10, pages 1954-1960.
Crossref
Crossref
L. M. Thorne-Humphrey, K. B. Goralski, K. L. Slayter, T. F. Hatchette, B. L. Johnston & S. A. McNeil. (2011) Oseltamivir pharmacokinetics in morbid obesity (OPTIMO trial). Journal of Antimicrobial Chemotherapy 66:9, pages 2083-2091.
Crossref
Crossref
Ryan D. Kinloch, Choon-Myung Lee, Nico van Rooijen & Edward T. Morgan. (2011) Selective role for tumor necrosis factor-α, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen. Biochemical Pharmacology 82:3, pages 312-321.
Crossref
Crossref
Lois D. Lehman‐McKeeman & William R. Foster. 2011. Applications of Toxicogenomics in Safety Evaluation and Risk Assessment. Applications of Toxicogenomics in Safety Evaluation and Risk Assessment
331
347
.
Marina Kacevska, Michael R. Downes, Rohini Sharma, Ronald M. Evans, Stephen J. Clarke, Christopher Liddle & Graham R. Robertson. (2011) Extrahepatic Cancer Suppresses Nuclear Receptor–Regulated Drug Metabolism. Clinical Cancer Research 17:10, pages 3170-3180.
Crossref
Crossref
Nienke J. Vet, Matthijs de Hoog, Dick Tibboel & Saskia N. de Wildt. (2011) The effect of inflammation on drug metabolism: a focus on pediatrics. Drug Discovery Today 16:9-10, pages 435-442.
Crossref
Crossref
Andrew J. McLachlan, Sally Bath, Vasi Naganathan, Sarah N. Hilmer, David G. Le Couteur, Stephen J. Gibson & Fiona M. Blyth. (2011) Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment. British Journal of Clinical Pharmacology 71:3, pages 351-364.
Crossref
Crossref
Piyanuch Wonganan, Courtney C. Clemens, Kathy Brasky, Lucio Pastore & Maria A. Croyle. (2010) Species Differences in the Pharmacology and Toxicology of PEGylated Helper-Dependent Adenovirus. Molecular Pharmaceutics 8:1, pages 78-92.
Crossref
Crossref
S. R. COX, S. LIAO, M. PAYNE-JOHNSON, R. J. ZIELINSKI & M. R. STEGEMANN. (2011) Population pharmacokinetics of mavacoxib in osteoarthritic dogs. Journal of Veterinary Pharmacology and Therapeutics 34:1, pages 1-11.
Crossref
Crossref
Xiaoye He, Stephen J. Clarke & Andrew J. McLachlan. (2011) Clinical Pharmacology of Chemotherapy Agents in Older People with Cancer. Current Gerontology and Geriatrics Research 2011, pages 1-6.
Crossref
Crossref
Jenna O. McNeil & Kerry B. Goralski. 2011. Drug Interactions in Infectious Diseases. Drug Interactions in Infectious Diseases
167
201
.
Hanna E. Silber, Claudia Burgener, Ingrid M. Letellier, Mathieu Peyrou, Martin Jung, Jonathan N. King, Philippe Gruet & Jerome M. Giraudel. (2010) Population Pharmacokinetic Analysis of Blood and Joint Synovial Fluid Concentrations of Robenacoxib from Healthy Dogs and Dogs with Osteoarthritis. Pharmaceutical Research 27:12, pages 2633-2645.
Crossref
Crossref
Ryota Kikuchi, Matthew McCown, Pamela Olson, Chise Tateno, Yoshio Morikawa, Yumiko Katoh, David L. Bourdet, Mario Monshouwer & Adrian J. Fretland. (2010) Effect of Hepatitis C Virus Infection on the mRNA Expression of Drug Transporters and Cytochrome P450 Enzymes in Chimeric Mice with Humanized Liver. Drug Metabolism and Disposition 38:11, pages 1954-1961.
Crossref
Crossref
M. MARTINEZ & S. MODRIC. (2010) Patient variation in veterinary medicine: part I. Influence of altered physiological states. Journal of Veterinary Pharmacology and Therapeutics 33:3, pages 213-226.
Crossref
Crossref
Yonas Getachew, Laura James, William M. Lee, Dwain L. Thiele & Bonnie C. Miller. (2010) Susceptibility to acetaminophen (APAP) toxicity unexpectedly is decreased during acute viral hepatitis in mice. Biochemical Pharmacology 79:9, pages 1363-1371.
Crossref
Crossref
V D Schmith & J F Foss. (2010) Inflammation: Planning for a Source of Pharmacokinetic/Pharmacodynamic Variability in Translational Studies. Clinical Pharmacology & Therapeutics 87:4, pages 488-491.
Crossref
Crossref
J.P. Luyendyk, R.A. Roth & P.E. Ganey. 2010. Comprehensive Toxicology. Comprehensive Toxicology
295
317
.
Rohini Sharma, David Cunningham, Paul Smith, Graham Robertson, Owen Dent & Stephen J Clarke. (2009) Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients – analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO. BMC Cancer 9:1.
Crossref
Crossref
Robert A. Roth & Patricia E. Ganey. 2009. The Liver. The Liver
773
781
.
Xiaomin Deng, James P. Luyendyk, Patricia E. Ganey & Robert A. Roth. (2009) Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal Models. Pharmacological Reviews 61:3, pages 262-282.
Crossref
Crossref
B. C. Foster. (2009) Therapeutic product disposition in at-risk populations. Radiation Protection Dosimetry 134:3-4, pages 184-190.
Crossref
Crossref
Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, Ronald P.J. Oude Elferink, David G. Besselsen, Robert P. Erickson & Nathan J. Cherrington. (2009) Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats. European Journal of Pharmacology 613:1-3, pages 119-127.
Crossref
Crossref
P Wonganan, W C Zamboni, S Strychor, J D Dekker & M A Croyle. (2008) Drug–virus interaction: effect of administration of recombinant adenoviruses on the pharmacokinetics of docetaxel in a rat model. Cancer Gene Therapy 16:5, pages 405-414.
Crossref
Crossref
Brad Moriyama, Jason Elinoff, Robert L. Danner, Juan Gea-Banacloche, Gennethel Pennick, Michael G. Rinaldi & Thomas J. Walsh. (2009) Accelerated Metabolism of Voriconazole and Its Partial Reversal by Cimetidine. Antimicrobial Agents and Chemotherapy 53:4, pages 1712-1714.
Crossref
Crossref
Géraldine Pettersen, Mohamad-Samer Mouksassi, Yves Théorêt, Line Labbé, Christophe Faure, Bao Nguyen & Catherine Litalien. (2009) Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patients. British Journal of Clinical Pharmacology 67:2, pages 216-227.
Crossref
Crossref
VA Nepomniashchikh, VV Lomivorotov, MN Deryagin, VN Lomivorotov & LG Kniazkova. (2009) Oxidative stress and monooxygenase liver function in patients with coronary heart disease and multiple organ dysfunction syndrome. European Journal of Anaesthesiology 26:2, pages 140-146.
Crossref
Crossref
Romi Ghose, Tao Guo & Nadia Haque. (2009) Regulation of gene expression of hepatic drug metabolizing enzymes and transporters by the Toll-like receptor 2 ligand, lipoteichoic acid. Archives of Biochemistry and Biophysics 481:1, pages 123-130.
Crossref
Crossref
Shellie M Callahan, Piyanuch Wonganan & Maria A Croyle. (2008) Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection. Virology Journal 5:1.
Crossref
Crossref
Tomoe Fujita, Shuichi Yasuda, Yuji Kamata, Kazumi Fujita, Yoshio Ohtani, Yuji Kumagai & Masataka Majima. (2008) Contribution of Down-Regulation of Intestinal and Hepatic Cytochrome P450 3A to Increased Absorption of Cyclosporine A in a Rat Nephrosis Model. Journal of Pharmacology and Experimental Therapeutics 327:2, pages 592-599.
Crossref
Crossref
VD Schmith & JF Foss. (2008) Effects of Inflammation on Pharmacokinetics/Pharmacodynamics: Increasing Recognition of Its Contribution to Variability in Response. Clinical Pharmacology & Therapeutics 83:6, pages 809-811.
Crossref
Crossref
Edward T. Morgan, Kerry B. Goralski, Micheline Piquette-Miller, Kenneth W. Renton, Graham R. Robertson, Madhusudana R. Chaluvadi, Kellie A. Charles, Stephen J. Clarke, Marina Kacevska, Christopher Liddle, Terrilyn A. Richardson, Rohini Sharma & Christopher J. Sinal. (2008) Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer. Drug Metabolism and Disposition 36:2, pages 205-216.
Crossref
Crossref
Kathleen Seitz & Ghui Zhou. (2013) Pharmacokinetic Drug‐Drug Interaction Potentials for Therapeutic Monoclonal Antibodies: Reality Check. The Journal of Clinical Pharmacology 47:9, pages 1104-1118.
Crossref
Crossref
Antonio J. Molina, Gracia Merino, Julio G. Prieto, Rebeca Real, Gracia Mendoza & Ana I. Alvarez. (2007) Absorption and metabolism of albendazole after intestinal ischemia/reperfusion. European Journal of Pharmaceutical Sciences 31:1, pages 16-24.
Crossref
Crossref